Vidwan-ID : 72121



  • Prof Anand Kumar Kondapi

  • Professor
  • University of Hyderabad
Publications 1987 - 2020

Publications

  • 69
    Journal Articles
  • 1
    Conference
    Proceedings
  • 3
    Review
  • 57
    Other
  • 30
    Projects
  • 11
  • 4
  • 3
  • 50

Citations / H-Index

1628 Citations
26 h-index
1289 Citations

Altmetrics

2
1
9
7
1

Co-author Network


Expertise

Biotechnology and Applied Microbiology

Molecular therapeutics, HIV, Cancer, Brain ageing

Personal Information

Prof Anand Kumar Kondapi

Male
Department of Biotechnology and Bioinformatics University of Hyderabad, Prof CR Rao Road, Gachibowli
Ranga Reddy, Telangana, India - 500046


Experience

  • Professor

    Department of Biotechnology

    University of Hyderabad

  • Reader

    Department of Biochemistry

    University of Hyderabad

  • Lecturer

    Department of Biotechnology

    University of Hyderabad

  • Research Associate

    Department of Biochemistry

    Indian Institute of Science, Bangalore


Qualification

  • Ph.D

    Andhra University


Honours and Awards

2014

Fellow of Telangana Akademy of Sciences

TSAS

2013

Fellow of AP Akademi Of Sciences

APAS

1996

Biotechnology Overseas Associateship (LT)

DBT

Read More
2014

Fellow of Telangana Akademy of Sciences

TSAS

2013

Fellow of AP Akademi Of Sciences

APAS

1996

Biotechnology Overseas Associateship (LT)

DBT

1990

NBTB Research Associateship

DBT

1988

Dr. K. S. Krishnan DAE Fellowship

DAE

Read Less

Doctoral Theses Guided

2017

Development of efficient and safe lactoferrin nanoparticles based MPT Microbicidal Drug delivery systems against HIV-1

Samrajya Lakshmi Y, University of Hyderabad

2017

Lactoferrin nanoparticles for tageted tumor therapy: Implications in blioblastoma and melanoma management

Sonali Day , University of Hyderabad

2016

Characterization of Ventral Mesencephalic neuron enriched culture in vitro: Correlation to Parkinson

V. Satish Bollimpally , University of Hyderabad

Read More
2017

Development of efficient and safe lactoferrin nanoparticles based MPT Microbicidal Drug delivery systems against HIV-1

Samrajya Lakshmi Y, University of Hyderabad

2017

Lactoferrin nanoparticles for tageted tumor therapy: Implications in blioblastoma and melanoma management

Sonali Day , University of Hyderabad

2016

Characterization of Ventral Mesencephalic neuron enriched culture in vitro: Correlation to Parkinson

V. Satish Bollimpally , University of Hyderabad

2016

Analysis of gene interaction networks in neuronal aging and HIV infection

Pankaj Singh Dholaniya , University of Hyderabad

2015

Characterization of anti HIV-1 activity of curcumin and its analogues and their delivery by apotransferrin nanoparticles

G Upendhar , University of Hyderabad

2015

Long term non-progressors of HIV-1 perinatally infected children: Vila Genetic and Immunological profile.

K. Sarada , University of Hyderabad

2014

HIV-1 Reverse Transcription: Role of Topoisomerase II isoforms and Topoisomerase II? kinase

S L Balakrishna, University of Hyderabad

2013

Characterization of TopoisomeraseII?-associated Base excision repair and Senescence in Cultured cerebellar granule neurons

Preeti Gupta , University of Hyderabad

2011

Design and Development of Epap-1 derived anti-HIV-1 peptides

C.Bhaskar, University of Hyderabad

2010

A study on DNA Topoisomerases during neuronal aging in vitro and in vivo

M. Uday Bhanu, University of Hyderabad

2008

Molecular mechanism of DNA Topoisomerase II isoforms in HIV-1 early replication

N. Satyanarayana , University of Hyderabad

2007

Cloning and expression of Epap-1 in Sf 9 cells and characterization of its anti-viral activities

K. P. Roda Rani , University of Hyderabad

2007

Isolation and characterization of Placental Epap-1 secreting endothelial cells and an analysis of anti-viral activity of recombinant Epap-1

P. Dheeraj, University of Hyderabad

2006

Identification and characterization of Topoisomerase II alpha and beta kinase activity in HIV-1 infected cells and virus particles

G. Padmaja , University of Hyderabad

2004

A study on the age dependent changes of Topoisomerase II alpha and Topoisomerase II beta isoforms in rat brain and sensitivity of Topoisomerase II isoforms to Topo II poisons

K. Neelima, University of Hyderabad

2003

Analysis and mechanism of action of anti-HIV active glycoprotein present during early pregnancy

M. A. Hafiz , University of Hyderabad

2000

A novel class of Topoisomerase II poisons containing iron and ruthenium: anticancer activity and targeted delivery

Y. N. Vashisht Gopal , University of Hyderabad

1999

Design and synthesis of anticancer cobalt complexes: Molecular mechanism of action on Topoisomerase II

D. Jayaraju, University of Hyderabad

Design

K. Kurumuthy , Synthesis and Development of Potential anti-HIV-1 Inhibitors

,

Characterization of Topoisomerase II activities in neuronal development

M. Rajakumar , DNA repair and HIV-1 induced inflammation

Design

A D Sai Krishna, Development and Nanoparticle based delivery of Topoisomerase II beta poisoning derivatives of Ferrocene

HIV-associated Topoisomerase II? kinase: Purification

P.Kannapiran, Characterization and Design of Inhibitors with anti-HIV-1 activity

Doxorubicin nanoformulations of apotransferrin and lactoferrin: Bioavailability

Golla Kishore , safety and efficacy in rat hepatocellular carcinoma

Regulatory activities of topoisomerase II beta in DNA repair

Ch. Anil Kumar , HIV-1 transcription and senescence

Development of Carboplatin

Farhan Ahmad , 5-Flurouracil and Oxaliplatin loaded protein nanoparticle formulation for chemotherapeutic application

Antiretroviral Drug loaded Lactoferrin nanoparticle formulation for oral delivery: Improved Efficacy

Prashanth Kumar, Bioavailability and Safety.

Read Less

Membership In Professional Bodies

2011

American Association of Phamaceutical Scienstists

Life Member

2010

Indian Science Congress

Life Member

2006

Indian Neuroscience Society.

Life Member

Read More
2011

American Association of Phamaceutical Scienstists

Life Member

2010

Indian Science Congress

Life Member

2006

Indian Neuroscience Society.

Life Member

1994

Association of DNA finger printing and other DNA technologies

Life Member

1988

Indian Society for Technical Education

India

Read Less

Membership In Committees

2018

Expert committee on Infectious Diseases Biology

Member

2015

Expert Committee on Molecular Diagnostics

Recombinant DNA

2015

Scientific Advisory Committee

Member

Read More
2018

Expert committee on Infectious Diseases Biology

Member

2015

Expert Committee on Molecular Diagnostics

Recombinant DNA

2015

Scientific Advisory Committee

Member

2010

Review Committee on Genetic Manipulation

Member

Read Less

Research Projects

Design and Synthesis of a new class of anti-cancer metal Complexes with topoisomerase II as a potential target.

Funding Agency : CSIR

Isolation

Funding Agency : 1600000

An analysis on topoisomerase II activation during HIV infection: Characterization of Topoisomerase II activation in primary events of HIV infection

Funding Agency : DST

Read More

Design and Synthesis of a new class of anti-cancer metal Complexes with topoisomerase II as a potential target.

Funding Agency : CSIR

Isolation

Funding Agency : 1600000

An analysis on topoisomerase II activation during HIV infection: Characterization of Topoisomerase II activation in primary events of HIV infection

Funding Agency : DST

Characterization of anti-HIV activities of early pregnancy associate protein 1 in vitro.

Funding Agency : DBT

Development of novel anti-HIV molecules based on through characterization of mechanism of action of Topoisomerase II inhibitors during HIV replication.

Funding Agency : DST

Supported Advanced Center for Research in Ageing Brain; Correlation of Topoisomerase II alpha and beta activities in ageing brain.

Funding Agency : ICMR

Development and targeted-delivery of Topoisomerase II isoform specific poisons and Evaluation of drug efficacy in rat cancer model.

Funding Agency : DBT

A study of HIV-1 envelope induced neurotoxicity in rat cerebellar neurons and astrocytes: Identification of non-neurotoxic HIV Vaccine candidates.

Funding Agency : ILS-UH

A monitoring and analysis of anti-HIV active early pregnancy associated proteins 1 & 2 in pregnant women.

Funding Agency : ICMR

Characterization of HIV-associated Topoisomerase II associated kinase activities.

Funding Agency : DST

Characterization of HIV-associated Topoisomerase II associated kinase activities.

Funding Agency : ICMR-Indo US Joint statement

Characterization of DNA repair and recombination activities of Topoisomerase II and novel polymerases in primary neurons.

Funding Agency : DST

Neuro-immune interactions in aging and immunodeficiency.

Funding Agency : ICMR

Characterization of anti-HIV properties of peptides derived from Epap-1.

Funding Agency : DBT

Characterization of Topoisomerase II beta associated senescence mechanisms in neurons in vitro and in vivo.

Funding Agency : DBT

Development of patentable HIV inhibitors targeted to HIV-1 associated Topoisomerase II beta kinase

Funding Agency : DST

Development of protein nanoparticles based microbicidal formulation in combination of curcumin and antiretroviral agent (NanoCurcARV)

Funding Agency : DBT-ICMR

Development of targeted

Funding Agency : 5200000

Molecular Characterization of function of Topoisomerase II alpha and beta during HIV-1 reverse transcription in early replication

Funding Agency : DST

Curcumin: A multi mechnism HIV microbicide

Funding Agency : ICMR Indo-US

Characterization of Epap-1 bound epitopes of gp120: Development of novel entry inhibitors

Funding Agency : DBT

Screening and mechanism of action of anti-HIV molecules

Funding Agency : Dr Reddy's Research Foundation

Evaluation of potency of the multiherbal preparation

Funding Agency : Envin Bioceuticals

Screening and analysis of HIV-1 protease inhibitors

Funding Agency : Hetero Drugs Ltd.

Screening Anti-HIV activity of Molecules

Funding Agency : Arabindo Research Centre

Screening and analysis of HIV-1 inhibitors

Funding Agency : Hetero Drugs Ltd.

Nanoformulation development

Funding Agency : V Life Technologies

Anti-HIV-1 screening

Funding Agency : AJ Orgnica Ltd

Pharmacological evaluation of Nanoofrmulation

Funding Agency : Aizant

Funding Agency :

Read Less